Insulet | PODD - Passifs Courants





Passifs Courants Changement Date
Abbott USD 18.38B 1.88B 2026-03
Align Technology USD 1.91B 4.9M 2026-09
AtriCure USD 81.92M 8.72M 2026-06
Baxter International USD 3.81B 218M 2026-09
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Boston Scientific USD 5.98B 446M 2026-09
Cardinal Health USD 43.9B 1.92B 2026-06
Cooper Companies USD 1.87B 61.9M 2026-06
Dexcom USD 2.25B 105.1M 2026-09
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Eli Lilly USD 47B 745M 2026-09
Globus Medical USD 479.35M 3.12M 2026-06
ICU Medical USD 498.36M 19.54M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 329M 1.88M 2026-09
J&J USD 55.46B 562M 2026-09
Medtronic USD 11.8B 141M 2026-06
Merit Medical Systems USD 265.08M 150K 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Solventum Corp USD 3.66B 317M 2026-06
Stryker USD 6.5B 184M 2026-09
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
West Pharmaceutical Services USD 644.3M 3.8M 2026-09
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06